Background Neuropathology has demonstrated a high rate of comorbid pathology in
dementia due to Alzheimer's disease (ADD). The most common major comorbidity is Lewy …

Background: Concomitant Alzheimer's disease (AD) pathology is observed in Lewy body
diseases (LBD), but the clinical impact is unknown. Only a few biomarker studies in LBD …

Objective To determine whether mild cognitive impairment with Lewy bodies or mild
cognitive impairment with Alzheimer disease differ in their rates of clinical progression to …

Abstract Background Dementia due to Alzheimer's disease (AD) and dementia with Lewy
bodies (DLB) are the two most common neurodegenerative causes of dementia. They …

Background and Objectives Evaluating and understanding the heterogeneity in dementia
course has important implications for clinical practice, health care decision-making, and …

Introduction As the identification of Lewy body dementia (LBD) is often confirmed
postmortem, there is a paucity of evidence on the progression of disease antemortem. This …

Objective To determine whether patients with Lewy body dementia (LBD) with likely
Alzheimer disease (AD)–type copathology are more impaired on confrontation naming than …

Objectives Authors compared the degrees of cognitive deficit among individuals with
Alzheimer disease (AD), the Lewy-body variant of AD (LBV), and “pure” dementia with Lewy …

Background: Alzheimer's disease neuropathologic change (ADNC) may contribute to
dementia in patients with Lewy body disease (LBD) pathology. Objective: To examine how …

Objective We explored whether the mild cognitive impairment (MCI) stages of dementia with
Lewy bodies (DLB) and Alzheimer disease (AD) differ in their cognitive profiles, and …